Statistics
Total Visits
| Views | |
|---|---|
| Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer | 1290 |
Total Visits per Month
| August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | |
|---|---|---|---|---|---|---|---|
| Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer | 4 | 6 | 2 | 2 | 0 | 6 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 1092 |
| United States | 144 |
| Canada | 6 |
| China | 6 |
| Ireland | 4 |
| Sweden | 4 |
| Ukraine | 4 |
| Argentina | 2 |
| France | 2 |
| India | 2 |
Top City Views
| Views | |
|---|---|
| Armidale | 798 |
| Yeronga | 180 |
| Ashburn | 54 |
| Melbourne | 42 |
| Louisville | 20 |
| San Mateo | 14 |
| Alameda | 12 |
| Bairnsdale | 12 |
| Sydney | 8 |
| Woollahra | 6 |